Story thread · 2 reports / 2 sources
Beam drops after updating Phase 1/2 trial data for gene-editing drug
seekingalpha.com · 6d
First report: #ERS26: Beam says AATD base editing data hold up after one year — endpts.com, 7d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.